The sharing of scientific data reinforces open scientific inquiry; it encourages diversity of analysis and opinion while promoting new research and facilitating the education of next generations of scientists. In this article, we present an initiative for the development of a repository containing continuous electrocardiographic information and their associated clinical information. This information is shared with the worldwide scientific community to improve quantitative electrocardiology and cardiac safety. First, we present the objectives of the initiative and its mission. Then, we describe the resources available in this initiative following 3 components: data, expertise, and tools. The data available in the Telemetric and Holter ECG Warehouse (THEW) includes continuous electrocardiogram signals and associated clinical information. The initiative attracted various academic and private partners whom expertise covers a large list of research arenas related to quantitative electrocardiography; their contribution to the THEW promotes cross-fertilization of scientific knowledge, resources, and ideas that will advance the field of quantitative electrocardiography. Finally, the tools of the THEW include software and servers to access and review the data available in the repository. To conclude, the THEW is an initiative developed to benefit the scientific community and to advance the field of quantitative electrocardiography and cardiac safety. It is a new repository designed to complement the existing ones such as Physionet, the American Heart Association -Beth Israel Hospital (AHA-BIH) arrhythmia database, and the Common Standard for Electrocardiography (CSE) database. The THEW hosts unique datasets from clinical trials and drug safety studies that, so far, were not available.
Introduction
Despite the effort implemented to reduce the number of sudden cardiac death in the United States by early advanced care, there is a clear need for the improvement of risk stratification techniques to optimize the use of prophylactic therapies such as implantable defibrillators and drug therapies. Meanwhile, cardiac safety is also one of the most challenging hurdles in the development of new molecular entities. It has been estimated that as many as 86% of all drugs tested in pharmaceutical development show specific inhibitory activity of potassium ion kinetics, which, in some cases, can lead to torsades de pointes and potentially to sudden cardiac death.
The University of Rochester Medical Center and the Heart Research follow-Up Program (NY) enabled the creation of the "Center for Quantitative Electrocardiography and Cardiac Safety" (CES). The CES activities are defined around (1) the development and maintenance of computer resources (data storage and computing center) for data sharing and analysis, (2) the deployment of platforms for the sharing of medical information, and (3) the formation of a scientific network to initiate collaborative research projects. The CES distributes the resources from the Telemetric and Holter ECG Warehouse (THEW) to the international scientific community, sharing unique clinical and electrocardiogram (ECG) infor-mation for the design and validation of technologies to improve quantitative electrocardiography and cardiac safety.
In addition, the THEW includes a partnership with the US Food and Drug Administration (FDA; see FDA privatepublic partnership in Appendix A). Under its public health mission, FDA is interested in the development of improved technologies to evaluate drug safety and efficacy. 1 This FDA partnership was designed to leverage resources and expertise toward the implementation of collaborative projects among FDA and other public and private stakeholders. Out of this collaborative effort, specific projects were started to expand the data in the CES repository (THEW) and facilitate scientific projects toward the development, testing, and validation of ECG-related technologies.
Finally, the THEW has developed collaborations with multiple academic centers in the United States and in Europe. Private corporations have submitted research proposals as well, and the initiative has spawned collaborative projects between academia and industries. In this article, we provide insights into the roles, the structures, and the resources we have developed that led to these achievements.
The THEW initiative

Mission statement
The objective of the THEW is to provide access to electrocardiographic data to research organizations for the design and validation of analytic methods to advance the field of quantitative electrocardiography with a strong focus on cardiac safety.
Information Technologies infrastructures
The overall infrastructure of the warehouse is schematized in Fig. 1 . The ECG signals from the warehouse are currently hosted in 2 servers: (1) a secured file transfer protocol (SFTP) server located at University of Buffalo (NY) and (2) a clientbased access server located at University of Rochester Medical Center (NY). Free access to the data is available to academic centers and to not-for-profit organizations.
Our resources include an IBM BlueGene/P super computer as well. The Blue Gene/P system consists of 1024 nodes, 4096 CPU cores, 2 TB of RAM, and 180 TB of storage. Access to this computer resource to THEW users is currently in development. The computer is hosted at the Rochester Center for Research Computing (see Appendix A).
Warehouse content ECG recordings
The data available in the warehouse were provided by research academic centers and major pharmaceutical companies. The current list of database is reported in Table 1 . The hosted ECG recordings are continuous with a length varying from 10 minutes to 24 hours. The ECG signals in the warehouse have different sampling frequency (180, 200, and Fig. 1 . Information technology structure for the THEW: 2 options are proposed to access the data from the THEW: (1) server hosted at the University of Buffalo using SFTP and (2) THEW CA, which is a dotNET client server application providing the access to both ECG signals and the associated clinical information. The THEW also include resources from a supercomputer (IBM BlueGene/P) that can be used in collaborative projects.
1000 Hz) and different amplitude resolution (coded on 10, 12, or 16 bits) depending on the database. The lead configuration depends also on the recording equipment. Currently, the datasets contain either 3-or 12-lead recordings. Three leads recordings are recorded using a pseudo-orthogonal configuration (X, Y, and Z). Twelve leads followed Holter configuration in which limb leads are referenced to the torso (treadmill configuration or Mason-Likar lead placement), and the precordial leads follow the standard resting 12-lead ECG configuration. The "ECG and annotation file formats" section describes the common format for the continuous ECG file and their annotation information across the databases.
Study populations in the repository
The THEW databases encompass ECG recordings from cardiac patients and healthy individuals. As described in Table 1 , 24-hour continuous Holter ECGs from patients with acute myocardial infarction, patients with coronary artery disease, 10-minutes continuous ECGs from patients before after cardioversion for atrial fibrillation, and finally patients with the congenital or the acquired long QT syndrome are included as well. In the list of patients with an history of torsades de pointes, it is worth noting that several of these patients had a diagnostic test based on dl-sotalol used to unmask latent repolarization abnormalities. 2 Electrocardiograms were recorded before, during, and after sotalol infusion. 3 Several of these recordings contain documented life-threatening ventricular arrhythmias (torsades de pointes).
In addition, 24-hour continuous Holter ECGs from healthy individuals are available. 4 A first set contains individuals in normal ambulatory condition, whereas the second set are individuals exposed to drug such as moxifloxacin (a drug used as positive control substance in drug safety trial to evaluate drug-induced QT interval prolongation, the socalled thorough QT studies). 5 Finally, the repository contains data from a full thorough QT study involving individuals exposed to a drug under development that did not reach the market because of its QT/QTc prolonging effect (study unique identifier: E-HOL-03-175-005). Electrocardiogram data from all arms of the study are available in the warehouse.
Detailed information regarding these populations is provided on the initiative web site (see Appendix A).
ECG and annotation file formats
The technical specifications of the data are documented by the ECG file format implemented in the warehouse, namely, the International Society for Holter and Noninvasive Electrocardiology (ISHNE) Holter ECG format. This format is extensively described by Badilini. 6 Because the ISHNE format does not include cardiac beat annotation, a hybrid version of this format was developed and shared by AMPS LLC (New York, NY), to host the information related to cardiac beat annotation. This format is defined as follow:
1. ISHNE header as described by Badilini, 
Clinical information
As noted above, the THEW consists of ECG recordings from cardiac patients, healthy individuals, and individual exposed to cardiac and to noncardiac drugs. The clinical information associated to these populations is heterogeneous. Consequently, we opted to release dataset-specific files to document the clinical information rather than deploying a global unified database. These clinical files are provided in either Microsoft Excel or SAS format. The list and the number of clinical variables in the clinical files vary between databases; a description of the database-specific set of information is provided in the THEW Web site. Importantly, none of the clinical information available in the THEW contains health private information, and all available information is fully compliant with the Health Insurance Portability and Accountability Act.
Accessing data from the THEW
All databases from the THEW are available worldwide through the Internet. The accesses to the SFTP sever or through the THEW client application (CA) require the same registration process. Because the THEW is supported by the National Heart, Lung, and Blood Institute, not-for-profit organizations can freely access the databases. However, we require these organizations to provide a single-page form describing their scientific objectives to the THEW Data Use Committee, which role is to provide feedback about potential collaborators (as an option), and scientific counseling to the submitter(s). Also, the THEW Data Use Committee receives users' feedback to improve data content, data structure, or organizational processes within the THEW. The submission form is available on the download area of our Web site (see Appendix A). For-profit organizations do not have to send such forms, but they are required to pay a membership fee to access the data from the repository.
The THEW CA
The THEW CA is a Microsoft dotNET (framework 2.0) application developed in collaboration with Global Instrumentations (Syracuse, NY). This application is designed to provide (1) easy secured access to ECG and clinical data, (2) an ECG viewer tool, (3) an ECG tool for interval (epochs) extraction from Holter recordings, (4) a system development kit based on a simple application program interface, and (5) a tool to download ECG signal and beat annotations. To obtain the latest version of the software, the users can send a request using the download area of our Web site (see Appendix A).
The epoch selection tool allows for identifying intervals of interest from the continuous ECG recordings (Fig. 2) . Once the epoch is defined, the CA provides an interface to download the period of interest so the users do not have to download large amount of signals (when it is not needed). The download tools of the CA provide several extraction formats such as ISHNE (as described in the "Warehouse content" section), HL7 XML (see Appendix A), and ASCII files with self-explanatory data format.
To simplify the users' access to relevant epochs of recordings, we predefined sets of epochs in each ECG recordings. For example, in our set of ECGs including druginduced torsades de pointes, we created epochs covering a period preceding the occurrence of the arrhythmias. This is illustrated in Fig. 2 . This information speeds up the review of the data or/and the creation of personal epochs.
In addition, the user can generate her/his own list of epochs that are stored on the client side and that can be retrieved as needed between sessions.
The SFTP server
The users of the THEW data have the option to access the data from the warehouse using an SFTP server hosted Legal use of the data from the THEW The data from the THEW can be used for research, development, and educational activities. No restriction exists related to publications, inventions, and patents, that is, intellectual properties based on the THEW data are fully owned by the inventor and cannot be claimed by either the THEW organization or the organization(s) that provided the data to the THEW.
Importantly, the data from the THEW cannot be shared between organizations without prior consent from the THEW organization (regardless of their status). Such requirement is necessary to have for-profit companies helping us continuing to develop our activities through membership data-access fees. Thus, we ask any THEW users to sign a Data Use Agreement stipulating that the data they obtain from our repository cannot be shared outside of their organization. As today, the Data Use Agreement was signed by more than 20 organizations worldwide.
Discussion
Helping the scientific community by developing an ECG repository is not a novel concept. There are several examples of ECG databases built over the past decades. The Massachusetts Institute of Technology (MIT) initiative around Physionet, and the American Heart AssociationBeth Israel Hospital (AHA-BIH) arrhythmia database, 7 and the Common Standard for Electrocardiography (CSE) database are examples of such ECG databases that benefited greatly scientists worldwide. The Physiobank 8 is probably one of the most successful initiative of ECG databases available today (see Appendix A). It has significantly contributed to the development of multiple ECG technologies. We believe that our initiative will complement the Physiobank ECG database for several reasons: (1) the CES will contain unique sets of ECGs and clinical data from regulatory clinical trials (not available in the Physiobank), and (2) our initiative will facilitate analysis of large sets of long-term digital Holter recordings; we host primarily 24-hour recordings. The ECG data contribution of the CES/ THEW is expected to grow at a fast pace. Over this past 2 years, our initiative has received ECG recordings from forprofit organizations and academic centers encompassing 1100 recordings from 785 individuals representing close to 270 GB of continuous digital ECGs. We expect to quadruple the size of the repository before the end of the year. Recently, we have developed further collaborations with centers from the United States and from Europe to add 2 large sets of data including more than 2000 recordings from (1) chest pain patients from the emergency department and( 2) genotyped congenital long QT syndrome patients. These new datasets will be available before the end of the year 2010.
Conclusion
The THEW initiative has rapidly grown. A stream of organizations is joining our initiative since his inceptive. We believe that our repository will benefit numerous scientists and researchers by providing unique set of continuous digital ECG recordings and their associated clinical information.
This initiative provides services to researchers worldwide by fostering and distributing resources (data and tools) needed to conduct ECG-related activities (technology development and ECG metrics). We expect this initiative to spawn various collaborative research projects and to facilitate the development of improved ECG technologies for cardiac safety.
More importantly, we believe that our effort will promote cross-fertilization of scientific knowledge, resources, and ideas that will advance the field of quantitative electrocardiography and cardiac safety.
Type of data signal (3 letters): HOL : Holter ambulatory ECGs TEL : telemetric ECGs STD : standard 12-lead resting ECGs OTH : other types of recording Number of leads included (2 digits). Number of recordings included in the database. Unique identification number (database entry order in the warehouse, 3 digits)
